EP2627334
Samsetningar til notkunar í meðferð við veirusýkingum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.10.2011EP published:
29.4.2015EP application number:
11833515.7
EP translation filed:
20.5.2015Grant published:
15.6.2015EPO information:
European Patent Register
Max expiry date:
13.10.2031Expiry date:
13.10.2026Next due date:
31.10.2026
Title:
COMPOSITIONS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS
Timeline
Today
14.10.2011EP application
29.4.2015EP Publication
20.5.2015Translation submitted
15.6.2015Registration published
13.10.2026Expires
Owner
Name:
Biocryst Pharmaceuticals, Inc.Address:
4505 Emperor Blvd., 27703, Durham, North Carolina, US
Inventor
Name:
BANTIA, ShantaAddress:
Birmingham AL, US
Name:
KOTIAN, Pravin, L.Address:
Birmingham AL, US
Name:
BABU, Yarlagadda, S.Address:
Birmingham AL, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
393522 PDate:
15.10.2010Country:
US
Number:
201161492054 PDate:
1.6.2011Country:
US
Classification
Categories:
A61K 31/519, A61K 31/215, A61K 45/06, A61P 31/14
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 10.9.2015
Expires: 13.10.2016
Payer: Árnason Faktor
Number: 6
Paid: 6.9.2016
Expires: 13.10.2017
Payer: Árnason Faktor
Number: 7
Paid: 11.9.2017
Expires: 13.10.2018
Payer: Árnason Faktor
Number: 8
Paid: 6.9.2018
Expires: 13.10.2019
Payer: Árnason Faktor
Number: 9
Paid: 28.4.2020
Expires: 13.10.2020
Payer: Patice ehf.
Number: 10
Paid: 9.9.2020
Expires: 13.10.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.9.2021
Expires: 13.10.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.9.2022
Expires: 13.10.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 19.10.2023
Expires: 13.10.2024
Payer: Pintz & Partners LLC
Number: 14
Paid: 29.8.2024
Expires: 13.10.2025
Payer: Pintz & Partners LLC
Number: 15
Paid: 18.8.2025
Expires: 13.10.2026
Payer: UAB METIDA